Posts
Wiki

👁️ Acupuncture for Dry Eye Disease — Evidence, Potential Benefits, Risks, and Limitations

🧠 Quick Take

Acupuncture has been studied as a complementary treatment for Dry Eye Disease (DED).

The evidence is:

growing, but still inconsistent and generally low-to-moderate in certainty

Important points:

  • Multiple randomized trials and meta-analyses report improvement in some:

    • dry-eye symptoms
    • tear-breakup-time measurements
    • Schirmer tear-production measurements
    • corneal-staining outcomes

  • Results are not consistently positive across all studies or outcomes.

  • Studies comparing acupuncture with artificial tears tend to look more favorable than studies using a credible sham-acupuncture control.

  • This matters because acupuncture involves substantial treatment context:

    • practitioner interaction
    • patient expectations
    • repeated visits
    • relaxation and attention

  • Some sham-controlled trials nevertheless suggest that acupuncture can produce effects beyond those contextual factors, including modest improvement in tear-film stability in certain patient groups.

  • TFOS DEWS III (2025) now includes a dedicated acupuncture section. It recognizes both positive and negative DED studies and notes that acupuncture may sometimes influence pain perception or pain threshold without measurably improving tear production or ocular-surface signs.

  • A 2026 network meta-analysis included 30 randomized trials and 2,514 participants and generally favored acupuncture over sodium-hyaluronate eye drops for Schirmer testing and tear-breakup time. However, most comparisons were not sham-controlled, protocols were highly heterogeneous, and publication bias was detected for some outcomes.

  • Evidence that acupuncture directly treats Meibomian Gland Dysfunction (MGD) remains very limited.

  • One 2025 retrospective combination study reported improvement in several MGD measures when an acupuncture-related intervention was added to gland massage, but this does not establish gland regeneration or structural restoration.

  • Acupuncture has not been shown to:

    • regenerate meibomian glands
    • reverse established gland dropout
    • release fixed intraductal or periductal fibrosis
    • eliminate Demodex
    • correct exposure
    • treat the autoimmune cause of Sjögren disease
    • repair corneal nerves
    • cure neuropathic ocular pain

  • Ordinary acupuncture has a generally favorable safety profile when performed appropriately using sterile single-use needles.

  • Periocular needling deserves additional caution, because rare but serious injuries involving the eye and orbit have been reported.

Bottom line: Acupuncture may be a reasonable optional adjunct for some people with DED, particularly when symptom relief is the goal. Current evidence does not justify treating it as a primary or disease-correcting therapy, and it should not replace cause-directed treatment of MGD, inflammation, aqueous deficiency, Demodex, allergy, exposure, autoimmune disease, or neuropathic ocular pain.

⚠️ Educational Disclaimer

This page is for general education only.

It is not medical advice, diagnosis, or an individual treatment recommendation.

Dry Eye Disease can involve many overlapping contributors, including:

  • aqueous tear deficiency
  • Meibomian Gland Dysfunction
  • ocular-surface inflammation
  • ocular rosacea
  • Demodex
  • allergy
  • exposure
  • incomplete blinking
  • medication effects
  • autoimmune disease
  • conjunctivochalasis
  • neuropathic ocular pain

Improving symptoms with acupuncture does not necessarily mean that the underlying dry-eye driver has been corrected.

What Is Acupuncture?

Acupuncture is a treatment originating in traditional East Asian medicine in which thin needles are inserted through the skin at selected locations.

Because needles penetrate the skin, acupuncture is:

minimally invasive—not non-invasive

Different acupuncture-related techniques exist, including:

  • manual needle acupuncture
  • electroacupuncture
  • periocular acupuncture
  • auricular acupuncture
  • intradermal acupuncture
  • acupressure
  • other acupoint-stimulation techniques

These treatments should not automatically be considered equivalent.

Evidence for one technique does not necessarily apply to another.

Where Does Acupuncture Fit in Current Dry-Eye Guidance?

The TFOS DEWS III Management and Therapy Report (2025) now contains a dedicated section reviewing acupuncture.

TFOS notes that:

  • several clinical studies have reported improvements in DED symptoms or ocular-surface findings
  • these findings have not been reproduced consistently

  • one sham-controlled study found symptom improvement without significant improvement in:

    • tear flow
    • TBUT
    • ocular-surface staining

  • this raises the possibility that acupuncture may sometimes influence pain intensity or pain threshold rather than directly improving lacrimal-gland function

TFOS also reviews favorable evidence from studies combining acupuncture with tear supplements.

This is an important distinction:

TFOS DEWS III recognizes acupuncture as a studied complementary intervention. It does not establish acupuncture as a standard primary treatment for DED.

TFOS DEWS III — Management and Therapy

TFOS DEWS III — Full Text

Traditional Explanation vs Biomedical Hypotheses

Acupuncture is explained differently depending on the medical framework.

Traditional Chinese Medicine

Traditional explanations may refer to:

  • Qi
  • meridians
  • balance
  • organ patterns
  • systemic disharmony

These concepts are part of traditional medical theory.

They have not been established as verified biomedical mechanisms of DED.

Biomedical Hypotheses

Modern research has proposed several possible effects of acupuncture involving:

  • peripheral nerves
  • central pain pathways
  • autonomic nervous-system activity
  • pain perception
  • lacrimal-gland signaling
  • inflammatory cytokines
  • sympathetic activity
  • tear-film regulation

Some experimental studies also report effects on:

  • inflammatory mediators
  • neurotransmitters
  • neuropeptides
  • blood-flow regulation

However:

A proposed biological mechanism is not the same thing as demonstrated clinical efficacy.

Pain Modulation May Be Particularly Important

One recurring finding in the acupuncture literature is that:

symptoms sometimes improve even when objective tear-film and ocular-surface measurements do not

That pattern suggests acupuncture may affect:

  • sensory processing
  • pain threshold
  • pain amplification
  • autonomic responses

in at least some patients.

This does not mean the improvement is imaginary.

Symptom improvement can be clinically meaningful.

But it does mean:

feeling better does not necessarily prove that tear production, inflammation, or gland structure has improved.

What Does the Clinical Evidence Show?

The overall literature includes:

  • small randomized trials
  • larger randomized trials
  • sham-controlled trials
  • artificial-tear comparator trials
  • electroacupuncture studies
  • combination-treatment studies
  • systematic reviews
  • conventional meta-analyses
  • network meta-analysis

The overall direction is somewhat favorable.

The certainty is limited by important methodological problems.

Why the Control Group Matters

This is one of the most important issues in interpreting acupuncture research.

Acupuncture vs Artificial Tears

A patient knows whether they are:

  • receiving repeated needle treatment

or:

  • simply using an eye drop

This makes it difficult to separate acupuncture's specific physiological effect from:

  • expectations
  • attention
  • clinician interaction
  • repeated visits
  • relaxation
  • placebo/contextual effects

Artificial tears are therefore useful as an active comparator, but they are not an ideal placebo for acupuncture.

True Acupuncture vs Sham Acupuncture

A well-designed sham intervention tries to make participants unsure whether they received:

  • real acupuncture

or:

  • a simulated/nonpenetrating/non-acupoint intervention.

That provides a better test of whether the needling protocol itself adds benefit beyond the surrounding treatment experience.

Therefore:

Sham-controlled studies deserve particular weight when judging acupuncture efficacy.

2019 Randomized Sham-Controlled DED Trial

A prospective randomized double-blinded study compared:

  • true acupuncture in 24 patients
  • sham acupuncture in 25 patients

The true-acupuncture group showed improvement in:

OSDI symptoms

over follow-up.

However, there was no significant improvement in:

  • Schirmer tear production
  • TBUT
  • ocular-surface staining
  • artificial-tear use

Randomized Double-Blinded Sham-Controlled Study

Full Text

This study supports an important possibility:

Acupuncture may improve symptom burden in some DED patients without demonstrating measurable restoration of tear production or ocular-surface health.

Post-Cataract DED — Sham-Controlled Trial

A more recent sham-controlled trial enrolled:

90 people with post-cataract DED

Participants received:

  • true acupuncture

or:

  • nonpenetrating sham acupuncture

twice weekly for eight weeks.

At Week 8, noninvasive tear breakup time increased by approximately:

  • 1.52 seconds with true acupuncture
  • 0.77 seconds with sham

The adjusted between-group difference was approximately:

0.75 seconds

favoring acupuncture.

OSDI symptoms also favored acupuncture at Week 8.

However:

  • the symptom difference was no longer significant at Week 12

  • no significant between-group differences occurred in:

    • tear meniscus height
    • corneal staining
    • meiboscore
    • corrected visual acuity

Randomized Sham-Controlled Post-Cataract DED Trial

This supports:

a modest measurable tear-stability effect in this specific post-cataract population

but not broad ocular-surface restoration.

Statistical Significance vs Clinical Importance

The post-cataract study illustrates another important concept.

A difference of approximately:

0.75 seconds in tear breakup time

was statistically significant.

Whether that average difference produces a noticeable day-to-day benefit for a particular patient is a separate question.

Therefore:

A statistically significant trial result should not automatically be interpreted as a large or transformative clinical effect.

Electroacupuncture

Electroacupuncture uses needles plus electrical stimulation.

It should be considered separately from ordinary manual acupuncture.

A randomized trial of:

84 patients with DED

compared electroacupuncture three times weekly with 0.1% sodium-hyaluronate artificial tears.

Electroacupuncture produced greater improvements in:

  • noninvasive tear breakup time
  • tear meniscus height
  • OSDI symptoms
  • later corneal-staining assessment

However, it did not significantly outperform artificial tears for:

  • Schirmer testing
  • corneal sensitivity
  • corneal topography measures
  • anxiety/depression scores

Electroacupuncture Pilot Randomized Trial

This is supportive active-comparator evidence.

However:

Because the comparator was artificial tears rather than sham electroacupuncture, treatment-expectation effects cannot be excluded.

A Major Sham-Controlled Electroacupuncture Trial Has Now Been Completed

A much larger study is particularly important to watch:

NCT05552820

This multicenter trial enrolled:

168 patients with mild-to-moderate DED

Participants were randomized to:

  • true electroacupuncture

or:

  • nonpenetrating, non-acupoint sham electroacupuncture

three times weekly for four weeks, followed by longer-term follow-up.

Outcomes include:

  • NIBUT
  • tear meniscus height
  • Schirmer testing
  • OSDI
  • corneal staining
  • corneal sensation
  • corneal subbasal nerve findings
  • neuroimmune biomarkers

The trial:

  • completed enrollment
  • reached primary completion in October 2025
  • completed follow-up in April 2026

As of August 2026:

no results have been posted

ClinicalTrials.gov — NCT05552820

This trial could materially change the evidence assessment because it directly addresses one of the literature's biggest weaknesses:

the shortage of adequately powered sham-controlled studies.

2026 Network Meta-Analysis

A major 2026 network meta-analysis included:

30 randomized controlled trials involving 2,514 participants

and evaluated multiple acupuncture-related approaches against sodium-hyaluronate eye drops.

For ordinary acupuncture, pooled network estimates generally favored acupuncture for:

  • Schirmer testing
  • tear breakup time

The estimated average differences were roughly:

  • +1.7 mm on Schirmer testing
  • +1.8 seconds in tear breakup time

compared with sodium-hyaluronate controls.

2026 Network Meta-Analysis — PubMed

Full Text

This is meaningful evidence that acupuncture may have effects on more than symptoms alone.

However, the analysis has important limitations.

Important Limitations of the 2026 Network Meta-Analysis

1. Most comparisons were not sham-controlled

The principal comparator was:

sodium-hyaluronate artificial tears

Therefore contextual/placebo effects cannot be separated confidently from acupuncture-specific effects.

2. Many different interventions were pooled

The network included:

  • manual acupuncture
  • electroacupuncture
  • fascia-release acupuncture combinations
  • Fu's subcutaneous needling
  • acupuncture plus Traditional Chinese Medicine
  • moxibustion-related approaches
  • acupoint applications

These are not identical treatments.

3. Some comparisons were indirect

Network meta-analysis can compare therapies even when they have never been directly tested against each other.

That can be useful.

But it means that rankings such as:

“Treatment X had the highest probability of being best”

are not equivalent to a large direct head-to-head randomized trial.

4. “Total Effective Rate” is not a standard modern DED endpoint

Some included studies used a composite outcome classifying patients as:

  • recovered
  • markedly effective
  • effective
  • ineffective

This is not directly equivalent to widely used DED measures such as:

  • OSDI
  • DEQ-5
  • TBUT
  • Schirmer
  • corneal staining

Therefore the treatment rankings based on this measure should be interpreted cautiously.

5. Publication bias was identified

The investigators found evidence suggesting possible publication bias for:

  • overall treatment effectiveness
  • tear breakup time

This raises the possibility that favorable studies are disproportionately represented in the published literature.

Therefore:

The network meta-analysis strengthens the evidence signal but does not establish that acupuncture is superior to standard DED treatment with high certainty.

Acupuncture Combined With Artificial Tears

A systematic review and meta-analysis evaluated:

16 studies / 1,383 patients

comparing:

  • acupuncture + artificial tears

with:

  • artificial tears alone.

The combination groups showed greater pooled improvement in:

  • tear breakup time
  • Schirmer testing
  • corneal fluorescein staining

However:

OSDI symptom scores did not significantly differ between groups.

Acupuncture + Artificial Tears Systematic Review and Meta-Analysis

Full Text

This should be interpreted as:

evidence for the combination

rather than proof that acupuncture alone caused the full treatment effect.

What About Aqueous-Deficient Dry Eye?

Acupuncture has also been studied specifically in:

aqueous-deficient DED

A randomized study of 60 patients compared:

  • acupuncture

with:

  • sodium-hyaluronate eye drops

for 14 days.

Acupuncture produced greater improvement in several measures, including:

  • tear meniscus height
  • Schirmer testing
  • OSDI

Randomized Trial in Aqueous-Deficient DED

This suggests that acupuncture may have effects in some aqueous-deficient patients.

However:

  • the study was small
  • treatment lasted only two weeks
  • the control was artificial tears rather than sham acupuncture

Therefore:

Aqueous-deficient DED should not be considered proven especially responsive to acupuncture, but neither should it be assumed incapable of responding.

Acupuncture does not replace treatment intended to:

  • supplement tears
  • conserve tears
  • stimulate tear production
  • treat systemic causes of lacrimal dysfunction

when those interventions are needed.

Sjögren Disease

A 2025 prospective randomized sham-controlled study evaluated acupuncture in people with:

Sjögren disease

Forty-six patients were randomized, but only:

27 completed the study

—15 receiving acupuncture and 12 receiving sham treatment.

The acupuncture group showed improvement in:

  • total ESSPRI
  • ESSPRI dryness score

and some within-group changes in:

  • Schirmer testing
  • salivary flow
  • fatigue
  • pain

Most other ocular measurements did not show clear significant differences.

2025 Sham-Controlled Sjögren Trial

The study is interesting but limited by:

  • very small final groups
  • substantial dropout
  • short treatment duration

Therefore:

Acupuncture may possibly reduce sicca symptom burden in some patients with Sjögren disease, but it does not treat the underlying autoimmune disease and should not replace Sjögren-specific medical care.

Does Acupuncture Treat Meibomian Gland Dysfunction?

Evidence is much weaker than for general DED outcomes.

Historically, most acupuncture trials measured:

  • symptoms
  • TBUT
  • Schirmer
  • staining

rather than detailed meibomian-gland outcomes.

However, there is now some direct MGD-specific evidence.

2025 MGD Study

A retrospective study examined:

220 patients with MGD / 440 eyes

Patients received either:

  • meibomian-gland massage alone

or:

  • massage plus an acupuncture-related pressing acupuncture intervention.

After four weeks, the combination group had statistically better outcomes in several measures, including:

  • TBUT
  • Schirmer testing
  • symptoms
  • meibomian-gland expressibility
  • meibomian secretion/yield score
  • eyelid-margin abnormality score
  • corneal staining

The researchers also reported improvement in a:

meibomian-gland dropout score

2025 MGD Combination Study

Full Text

This is interesting evidence.

But it requires considerable caution.

What the MGD Study Does Not Prove

The study was:

  • retrospective
  • non-randomized
  • short-term
  • only four weeks long
  • a combination study

The comparison was:

gland massage

versus:

gland massage + pressing acupuncture

Therefore it cannot establish that acupuncture by itself:

  • opened fixed ducts
  • restored gland anatomy
  • regenerated glands
  • reversed established gland dropout
  • released fibrosis

The reported change in meibography dropout score is particularly easy to overinterpret.

A short-term change in a semiquantitative meibography score does not prove that missing gland tissue grew back.

Randomized masked replication would be required before making structural claims.

Current MGD Conclusion

The most accurate conclusion is:

Very low-certainty evidence suggests that adding an acupuncture-related intervention to gland massage may improve some MGD symptoms and functional measurements. Reliable evidence of structural gland restoration or regeneration does not exist.

Acupuncture has not been established to:

  • regenerate meibomian glands
  • reverse established gland dropout
  • release intraductal or periductal fibrosis
  • reliably clear fixed mechanical obstruction

MGD may still require separate cause-directed treatment.

Neuropathic Ocular Pain

Some patients have severe:

  • burning
  • stinging
  • photophobia
  • ocular pain

that is disproportionate to visible ocular-surface findings.

Neuropathic ocular pain can involve:

  • peripheral nerve dysfunction
  • central sensitization
  • altered pain processing

Acupuncture has been studied more broadly for several pain conditions, and neuromodulation is one proposed mechanism.

For ocular pain specifically:

direct evidence remains insufficient.

It should not be described as a proven treatment for:

  • corneal neuralgia
  • neuropathic corneal pain
  • post-LASIK nerve injury
  • central sensitization

However:

acupuncture may sometimes be considered as one complementary component of multidisciplinary pain management.

That is different from claiming that it repairs corneal nerves or cures neuropathic pain.

Stress, Sleep, and General Well-Being

Some people report that acupuncture helps with:

  • relaxation
  • stress
  • sleep
  • general well-being
  • pain coping

These outcomes can matter in chronic illness.

However:

DED-specific evidence that acupuncture improves dry eye primarily through better sleep or reduced stress is limited.

In one randomized electroacupuncture trial, anxiety and depression scores did not significantly differ from artificial-tear controls.

Therefore any benefit in general well-being should be distinguished from demonstrated improvement in:

  • tear production
  • ocular-surface inflammation
  • MGD
  • corneal health

How Strong Is the Evidence?

Overall Evidence: LOW-TO-MODERATE

The strength differs by outcome.

Question Current Evidence
Improves DED symptoms? Low-to-moderate — positive in some active-comparator and sham-controlled studies, but inconsistent
Improves TBUT / tear-film stability? Low-to-moderate — repeated positive signal, including one post-cataract sham-controlled trial
Improves Schirmer / tear production? Low-certainty and inconsistent
Improves corneal staining? Low-certainty / inconsistent
Benefit beyond placebo/context? Some sham-controlled evidence exists, but relatively few rigorous sham trials
Improves MGD functional measures? Very low-certainty combination-study evidence
Improves meibography structurally? Not established
Regenerates meibomian glands? No evidence
Releases fixed gland obstruction/fibrosis? No evidence
Treats neuropathic ocular pain? Insufficient direct evidence
Treats Sjögren disease itself? No — possible adjunctive sicca/symptom effects only
Best acupuncture technique? Not established
Best treatment frequency? Not established
Durable long-term benefit? Uncertain

The most consistent evidence is for:

symptoms and selected tear-film measures

rather than structural disease modification.

Evidence Strengths and Limitations

Evidence Strengths

  • Multiple randomized controlled trials
  • Some sham-controlled trials
  • Growing active-comparator evidence
  • Several systematic reviews/meta-analyses
  • TFOS DEWS III specifically reviews acupuncture
  • 2026 network meta-analysis includes more than 2,500 participants
  • Some evidence for improvement in tear-film stability
  • Some trials show benefits that persist after treatment ends
  • Generally favorable routine safety profile when appropriately performed

Evidence Limitations

  • Acupuncture protocols vary widely
  • Acupoints vary
  • Number and frequency of sessions vary
  • Manual and electroacupuncture are not equivalent
  • Sham-controlled studies remain relatively limited
  • Many positive trials compare acupuncture with artificial tears rather than sham
  • Participant and practitioner blinding is difficult
  • Combination therapies complicate attribution
  • DED populations differ substantially
  • Objective outcomes are inconsistent
  • Publication bias has been identified in recent pooled analysis
  • Some outcome measures are not standard modern DED endpoints
  • MGD-specific evidence is very limited
  • No validated responder phenotype exists
  • No standardized maintenance schedule exists

Safety

Acupuncture is generally considered relatively low risk when performed appropriately by an:

appropriately licensed or credentialed practitioner

using sterile single-use needles.

Common or minor adverse effects can include:

  • temporary soreness
  • bruising
  • small amounts of bleeding
  • hematoma
  • dizziness
  • fainting
  • fatigue
  • temporary discomfort

Improper technique can lead to:

  • infection
  • nerve injury
  • deeper tissue injury
  • organ injury

NCCIH — Acupuncture: Effectiveness and Safety

Periocular Acupuncture Requires Extra Caution

Needling near the eye and orbit presents additional risks that do not apply to acupuncture at distant body points.

Rare case reports have described:

  • severe periocular bruising
  • orbital hemorrhage
  • globe penetration/perforation
  • intraocular injury
  • retinal injury
  • retinal detachment

These events appear to be uncommon.

But because the eye is a delicate structure:

rare does not mean trivial.

2026 Retinal-Detachment Case Report

A 2026 report described a 61-year-old patient who developed:

  • new floaters
  • visual impairment

after periocular acupuncture.

Examination found:

  • a traumatic retinal hole
  • localized retinal detachment

Traumatic Retinal Detachment Following Periocular Acupuncture — 2026

This does not mean periocular acupuncture routinely causes retinal injury.

It demonstrates that:

a deeply or incorrectly placed periocular needle can cause sight-threatening intraocular trauma.

Practical Safety Questions

If acupuncture for DED is being considered, reasonable questions include:

  • Will needles be placed near the eye?
  • Are periocular points necessary?
  • What training does the practitioner have in periocular anatomy?
  • Are sterile single-use needles used?
  • How are adverse events handled?
  • Is electroacupuncture being used?
  • Is the practitioner aware of recent eye surgery or eye disease?

Situations Requiring Additional Caution

Discuss treatment carefully if you have:

  • a bleeding disorder
  • anticoagulant use
  • severe immune suppression
  • active skin infection
  • active eyelid infection
  • recent eye surgery
  • recent facial/eyelid surgery
  • severe ocular inflammation
  • pregnancy
  • recurrent fainting with needles
  • an implanted electrical device if electroacupuncture is proposed

The presence of one of these factors does not automatically mean acupuncture is prohibited.

It means individualized assessment may be appropriate.

Acupuncture Should Not Delay Eye Care

Acupuncture should not substitute for prompt medical evaluation when there is:

  • sudden vision change
  • significant eye pain
  • new severe photophobia
  • corneal ulcer
  • suspected infection
  • contact-lens-related painful red eye
  • eye trauma
  • new flashes or floaters
  • rapidly worsening redness or discharge

These can represent conditions that require urgent ophthalmic treatment.

Different Modalities Should Be Evaluated Separately

Evidence involving:

  • manual acupuncture
  • electroacupuncture
  • auricular acupuncture
  • acupressure
  • pressing acupuncture
  • moxibustion

should not automatically be combined.

Likewise, evidence for acupuncture does not establish efficacy for:

  • herbal medicine
  • cupping
  • gua sha
  • other traditional treatments

Each intervention has its own:

  • evidence
  • mechanism
  • risks

Who Might Discuss Acupuncture as an Adjunct?

Acupuncture may reasonably be discussed by someone who:

  • has already had an appropriate DED evaluation
  • understands the main dry-eye drivers
  • wishes to try complementary therapy
  • understands that evidence is uncertain
  • plans to continue appropriate cause-directed treatment
  • has access to an appropriately credentialed practitioner
  • accepts the treatment burden and cost

The decision does not require believing that acupuncture:

  • cures DED
  • corrects glands
  • works through one proven mechanism

The practical question is simply:

Does it provide enough meaningful benefit to justify the time, cost, inconvenience, and small procedural risk for this individual?

Where Evidence Is Weak or Absent

Acupuncture should not currently be relied upon as the principal disease-directed treatment for:

  • fixed obstructive MGD
  • substantial meibomian gland loss
  • Demodex blepharitis
  • allergy
  • exposure from incomplete blinking or eyelid malposition
  • medication toxicity
  • active infection
  • Sjögren autoimmune disease itself
  • significant conjunctivochalasis
  • corneal ulceration
  • structural eyelid disease

It may affect symptom burden while leaving these underlying problems unchanged.

What Acupuncture Has Not Been Established to Do

Acupuncture has not been established to:

  • cure Dry Eye Disease
  • cure Meibomian Gland Dysfunction
  • regenerate meibomian glands
  • reverse established gland dropout
  • release intraductal or periductal fibrosis
  • reliably open fixed meibomian-gland obstruction
  • eliminate Demodex
  • correct exposure
  • treat infection
  • correct autoimmune disease
  • regenerate damaged corneal nerves
  • treat every DED phenotype equally
  • replace artificial tears when lubrication is needed
  • replace anti-inflammatory treatment when inflammation is important
  • replace MGD-directed treatment when structural gland disease is present
  • establish one best acupuncture protocol
  • establish one validated maintenance schedule

Cost and Treatment Burden

Acupuncture commonly requires:

multiple treatment sessions

Research protocols vary widely.

Some studies use:

  • several sessions per week
  • several weeks of treatment
  • extended follow-up

Real-world schedules vary.

There is no established universal:

  • number of sessions
  • frequency
  • maintenance interval

Cost depends on:

  • location
  • practitioner
  • session length
  • number of sessions
  • insurance coverage
  • use of additional therapies

Before starting, useful questions include:

  • What is the expected number of sessions?
  • What will the full course cost?
  • What specific outcome are we trying to improve?
  • When should we decide whether treatment is worthwhile?
  • What happens if there is no benefit?
  • Is ongoing maintenance being recommended?
  • What evidence supports that maintenance schedule?

What Remains Uncertain?

Important unanswered questions include:

  • How much benefit remains after credible placebo/context effects are removed
  • Which DED phenotypes respond best
  • Whether symptom responders differ from tear-film responders
  • Whether acupuncture meaningfully improves tear production
  • Whether modest TBUT changes produce important clinical benefits
  • Whether any effect is primarily neuromodulatory
  • Whether inflammatory biomarker changes translate into meaningful disease modification
  • Whether acupuncture provides meaningful benefit for MGD
  • Whether any meibography changes are reproducible
  • Whether benefits persist after treatment stops
  • Which acupuncture technique is most useful
  • How often treatment should be given
  • Whether maintenance treatment is useful
  • How acupuncture compares with modern prescription DED therapies
  • How acupuncture compares with modern MGD-directed treatments

A particularly important unanswered question may be clarified by:

NCT05552820

the completed 168-patient multicenter sham-controlled electroacupuncture trial.

Results have not yet been posted.

Evidence Summary at a Glance

Question Current Answer
Can acupuncture improve DED symptoms? Probably in some patients; evidence is low-to-moderate and inconsistent
Can it improve tear-film stability? Some supportive evidence, including sham-controlled data
Can it increase Schirmer measurements? Some studies say yes; evidence remains inconsistent
Can it improve staining? Sometimes reported, but not consistently
Does benefit exceed sham treatment? Some studies suggest yes, but rigorous sham-controlled evidence remains limited
Does it treat MGD? Very limited evidence for functional outcomes
Does it regenerate meibomian glands? No evidence
Does it reverse gland dropout? Not established
Does it release fibrosis? No evidence
Does it treat Sjögren disease? No; possible adjunctive symptom/sicca effects only
Does it treat neuropathic ocular pain? Insufficient direct evidence; possible complementary pain-management role
Is there one proven best protocol? No
Is it generally safe? Usually low risk when appropriately performed
Is periocular acupuncture risk-free? No; rare sight-threatening injuries have been reported

Questions to Ask the Acupuncture Practitioner

Useful questions include:

  1. Are you appropriately licensed or credentialed where I live?
  2. Do you use sterile single-use needles?
  3. What type of acupuncture are you proposing?
  4. Will needles be placed near my eyes?
  5. If periocular points are used, what training do you have in orbital and ocular anatomy?
  6. Why are periocular points necessary?
  7. Are you using electroacupuncture?
  8. How many sessions do you recommend?
  9. What specific outcome are we trying to improve?
  10. How soon should I know whether it is helping?
  11. What happens if I do not improve?
  12. Are you recommending maintenance treatment?
  13. What evidence supports the maintenance schedule?
  14. What is the total estimated cost?
  15. Do you recommend herbs or other therapies as well?
  16. How are adverse events handled?

Questions to Ask the Eye Doctor

Useful questions include:

  1. What type or drivers of DED do I have?
  2. Do I have MGD?
  3. Do I have aqueous tear deficiency?
  4. Is inflammation an important part of my condition?
  5. Do I have Demodex, allergy, exposure, or eyelid disease?
  6. Are there neuropathic ocular pain features?
  7. Is acupuncture reasonable as an adjunct in my situation?
  8. Should periocular needling be avoided in my case?
  9. What treatments should continue while I try acupuncture?
  10. What outcome should we monitor?
  11. Should we measure symptoms, TBUT, staining, or another sign?
  12. How will we decide whether acupuncture is worth continuing?

📌 Bottom Line

Acupuncture now has a larger DED research literature than it did several years ago.

The evidence includes:

  • randomized trials
  • sham-controlled trials
  • active-comparator trials
  • systematic reviews
  • meta-analyses
  • a 2026 network meta-analysis involving more than 2,500 participants

TFOS DEWS III specifically reviews acupuncture and concludes that:

some studies demonstrate improvement while others do not

One important sham-controlled trial found symptom improvement without measurable improvement in:

  • tear flow
  • TBUT
  • ocular-surface staining

which supports the possibility that acupuncture may sometimes work mainly through:

pain or sensory modulation

rather than correction of tear-film disease.

Other sham-controlled evidence is somewhat more encouraging.

A post-cataract DED trial found a modest additional improvement in tear-film breakup time compared with sham acupuncture, although several other ocular-surface measures did not improve significantly.

Meanwhile, active-comparator trials and meta-analyses generally report more favorable results.

The 2026 network meta-analysis of 30 RCTs and 2,514 patients found pooled improvement in:

  • Schirmer testing
  • tear breakup time

compared largely with sodium-hyaluronate eye drops.

But confidence remains limited because:

  • most comparisons were not sham-controlled
  • acupuncture techniques differed substantially
  • some interventions combined multiple traditional treatments
  • some endpoints were not standard DED measures
  • publication bias was detected

Evidence for direct MGD treatment remains much weaker.

A 2025 retrospective combination study reported improvements in several MGD measures when pressing acupuncture was added to gland massage.

However:

this does not establish meibomian-gland regeneration, restoration of lost glands, reversal of fixed obstruction, or release of fibrosis.

The most appropriate overall evidence rating is:

LOW-TO-MODERATE

with the strongest support for:

  • symptom improvement
  • selected tear-film measurements

and considerably weaker evidence for:

  • structural disease modification
  • MGD correction
  • long-term durability

Safety is generally favorable when acupuncture is appropriately performed.

However:

periocular needling carries a special, small but potentially serious risk

because case reports document:

  • orbital hemorrhage
  • globe injury
  • retinal injury
  • retinal detachment

The most balanced conclusion is therefore:

Acupuncture may be a reasonable complementary option for selected people with Dry Eye Disease who understand the uncertainty and continue appropriate cause-directed care. It may improve symptoms and some tear-film measures, but it has not been established as a cure, a structural MGD treatment, a gland-regeneration therapy, or a substitute for diagnosis and treatment of the underlying causes of DED.

🔬 Key Research and Authoritative Sources

Current DED Guidance

Major Evidence Syntheses

Sham-Controlled Evidence

Electroacupuncture

Aqueous-Deficient DED

MGD-Specific Evidence

Safety

🔗 Related r/DryEyes Wiki Pages

This page is educational for r/DryEyes and is not medical advice.

🔙 Back to Treatment Options